High TRIM11 expression was also recognized as an independent marker of poor prognosis in patients with breast cancer, colon and prostate adenocarcinoma, lung NSCC, HCC, and glioblastoma and it has also been correlated with advanced disease stage. The gene discussed is TRIM11; the disease is glioblastoma.